Gene · 8065
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DEMO-EM2: assembling protein complex structures from cryo-EM maps through intertwined chain and domain fitting. | Brief Bioinform | 2024 | 38517699 | PubTator, text mining | PubMed |
| The CRL5-SPSB3 ubiquitin ligase targets nuclear cGAS for degradation. | Nature | 2024 | 38418882 | Swiss-Prot, curated | PubMed |
| Proapoptotic effect of WS-299 induced by NOXA accumulation and NRF2-counterbalanced oxidative stress damage through targeting RBX1-UBE2M interaction in gastric cancers. | Bioorg Chem | 2024 | 38280358 | PubTator, text mining | PubMed |
| JAK/STAT in leukemia: a clinical update. | Mol Cancer | 2024 | 38273387 | PubTator, text mining | PubMed |
| Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review. | Int J Mol Sci | 2024 | 38255778 | PubTator, text mining | PubMed |
| The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells. | Nat Commun | 2024 | 38242867 | PubTator, text mining | PubMed |
| A computational exploration of global and temporal dynamics of selection pressure on HIV-1 Vif polymorphism. | Virus Res | 2024 | 38237808 | PubTator, text mining | PubMed |
| ARMC5 controls the degradation of most Pol II subunits, and ARMC5 mutation increases neural tube defect risks in mice and humans. | Genome Biol | 2024 | 38225631 | PubTator, text mining | PubMed |
| Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila. | Nat Commun | 2024 | 38212312 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy. | Biol Direct | 2024 | 38178263 | PubTator, text mining | PubMed |
| Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity. | Nat Commun | 2024 | 38177117 | PubTator, text mining | PubMed |
| Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | Biophys J | 2024 | 38115583 | PubTator, text mining | PubMed |
| ELM-the Eukaryotic Linear Motif resource-2024 update. | Nucleic Acids Res | 2024 | 37962385 | PubTator, text mining | PubMed |
| Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma. | Transl Oncol | 2024 | 37925796 | PubTator, text mining | PubMed |
| Comprehensive view of macrophage autophagy and its application in cardiovascular diseases. | Cell Prolif | 2024 | 37434325 | PubTator, text mining | PubMed |
| CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis. | bioRxiv | 2024 | 37398204 | PubTator, text mining | PubMed |
| High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data. | Front Physiol | 2023 | 38304289 | PubTator, text mining | PubMed |
| Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology. | Front Pharmacol | 2023 | 38235113 | PubTator, text mining | PubMed |
| Peripheral Neuropathy and Decreased Locomotion of a RAB40B Mutation in Human and Model Animals. | Exp Neurobiol | 2023 | 38196136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8065/papers?page=4